Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults

Sponsor
University of Calgary (Other)
Overall Status
Completed
CT.gov ID
NCT02217579
Collaborator
General Mills (Industry)
132
1
4
48
2.8

Study Details

Study Description

Brief Summary

The metabolic syndrome is rising worldwide as a consequence of the continued obesity epidemic. The current obesogenic environment makes the regulation of energy intake difficult and impedes the maintenance of weight loss. Dietary patterns and/or ingredients that curb hunger and reduce energy intake are critically needed. We hypothesize that inclusion of protein and prebiotic fiber in the diet will reduce adiposity in overweight and obesity adults.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Protein
  • Dietary Supplement: Prebiotic fiber
  • Dietary Supplement: Protein plus prebiotic fiber
  • Dietary Supplement: Control
N/A

Detailed Description

The main objective of our study is to assess the effects of protein and prebiotic fiber intake on changes in adiposity in an overweight and obese adult population.

Primary objective - To determine the effect of 12 week protein (10 g/day) or prebiotic fiber (16 g/day) intake on changes in body composition, chiefly body fat.

Secondary objective - To measure changes in appetite following 12 weeks of protein (10 g/day) or prebiotic fiber (16 g/day) intake.

Other outcomes includes changes in quality of life ratings and gut microbiota.

Study Design

Study Type:
Interventional
Actual Enrollment :
132 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults
Actual Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control

Isocaloric food without the test protein and prebiotic fiber.

Dietary Supplement: Control
An isocaloric food not containing the test protein and fiber.

Experimental: Protein

Dietary protein consumed as two daily servings of 5 grams protein/serving.

Dietary Supplement: Protein
A food containing 5 grams/serving of supplemental protein.

Experimental: Fiber

Prebiotic fiber consumed as two daily servings of 8 grams protein/serving.

Dietary Supplement: Prebiotic fiber
A food containing 8 grams/serving of supplemental prebiotic fiber.

Experimental: Protein plus prebiotic fiber

Protein and prebiotic fiber consumed as two daily servings of 5 grams protein/serving plus 8 grams fiber/serving.

Dietary Supplement: Protein plus prebiotic fiber
A food containing supplemental protein (5 grams/serving) and prebiotic fiber (8 grams/serving).

Outcome Measures

Primary Outcome Measures

  1. Change in baseline fat mass at 12 weeks [12 weeks]

    Assessed with dual energy x-ray absorptiometry.

Secondary Outcome Measures

  1. Change in baseline appetite at 12 weeks [12 weeks]

    Subjective appetite assessed with visual analog scales and objective appetite with a weighed lunch buffet.

Other Outcome Measures

  1. Change in baseline quality of life rating at 12 weeks [12 weeks]

    Measured with SF-36 questionnaire

  2. Change in baseline gut microbiota at 12 weeks [12 weeks]

    Measured by high throughput sequencing

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females

  • Age 18 - 70 years

  • BMI 25 - 38 kg/m-2

  • Stable body weight for at least 3 months prior to the study

Exclusion Criteria:
  • Type 1 diabetes

  • Clinically significant cardiovascular, liver or pancreas disease

  • Major gastrointestinal surgeries

  • Pregnant or lactating

  • Concomitant use of any weight loss medication, diet or exercise regime

  • Antibiotic use in the preceding 3 months to enrollment

  • Weight loss > 3 kg within preceding 3 months to enrollment

  • Use of bulk laxatives, fiber supplements or probiotic/prebiotic supplements

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Calgary Calgary Alberta Canada T2N 1N4

Sponsors and Collaborators

  • University of Calgary
  • General Mills

Investigators

  • Principal Investigator: Raylene A Reimer, PhD, RD, University of Calgary

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Raylene Reimer, Professor, University of Calgary
ClinicalTrials.gov Identifier:
NCT02217579
Other Study ID Numbers:
  • UofC Protocol REB13-0169
First Posted:
Aug 15, 2014
Last Update Posted:
Oct 26, 2017
Last Verified:
Oct 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Dr. Raylene Reimer, Professor, University of Calgary
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2017